CIRCA Texting Platform for Pregnancy

(CIRCA Trial)

This trial aims to recruit pregnant women in the Philadelphia area to use a new texting platform called CIRCA. CIRCA employs artificial intelligence to deliver helpful responses and educational content via text messages. The goal is to determine if enough participants join to ensure the trial's success. The trial seeks pregnant women who are less than 13 weeks along, have a working mobile phone, and can read English. As an unphased trial, it offers participants the opportunity to contribute to innovative research that could enhance prenatal care through technology.

The trial information does not specify whether you need to stop taking your current medications.

Studies have shown that the CIRCA Texting Platform helps pregnant individuals communicate more easily with healthcare providers. It uses artificial intelligence to provide quick and accurate answers to questions and share important information.

As a digital tool rather than a medicine, CIRCA does not have drug-like side effects. The primary safety concerns involve privacy and security, ensuring that personal information shared through the platform remains protected. CIRCA aims to reduce stress and confusion during pregnancy by facilitating easier access to care.

Researchers are excited about the CIRCA Texting Platform for pregnancy because it leverages artificial intelligence to provide personalized support and education to expectant mothers. Unlike traditional prenatal care, which often relies on scheduled in-person visits and static educational materials, CIRCA offers a dynamic, two-way communication system that matches patient texts to clinician-vetted responses. This innovative approach aims to deliver timely and relevant information, potentially improving engagement and outcomes for pregnant individuals by making support more accessible and responsive to their immediate needs.

Research has shown that receiving support through text messages during pregnancy can reduce the risk of complications around birth compared to regular prenatal care alone. In this trial, participants will use the CIRCA texting platform, which sends reliable, doctor-approved information about pregnancy and prenatal care directly to patients through automated texts. This service aims to assist pregnant individuals from the time they learn of their pregnancy by providing timely educational content. Although specific data on CIRCA's effectiveness is not yet available, studies suggest that text message support during pregnancy can lead to better outcomes.¹²³⁵⁶